FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022320883> ?p ?o ?g. }

• W2022320883 endingPage "104" @default.
• W2022320883 startingPage "102" @default.
• W2022320883 abstract "One in 4 Americans will die of heart disease or stroke, and 60% will have a major vascular event before they die.1 Recognizing this burden on public health, the American College of Cardiology and American Heart Association jointly released 4 new prevention guidelines in November 2013. These guidelines focused on lifestyle management to reduce cardiovascular risk,2 management of overweight and obesity,3 assessment of cardiovascular risk,4 and treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk.5 These evidence-based guidelines were developed through a rigorous process involving careful consideration of an extensive body of high-quality evidence derived from randomized controlled trials and systematic reviews and meta-analyses of randomized controlled trials in answering critical questions in clinical decision making. Key recommendations from each of the prevention guidelines are listed in the Table. Please refer to the published guidelines for details and comprehensive recommendations.TABLE: Key Recommendations in the New Cardiovascular Prevention GuidelinesThe new guidelines recommend new risk assessment and treatment strategies. The Assessment of Cardiovascular Risk guideline recommends a new model for estimating risk for atherosclerotic cardiovascular disease (ASCVD).4 Risk estimation is based on group averages that are then applied to individual patients in practice. The approach balances an understanding of an individual’s absolute risk for ASCVD and potential treatment benefits against the potential risks for harm from therapy. The Treatment of Blood Cholesterol guideline recommends a new strategy involving focus on reducing ASCVD risk in 4 major statin benefit groups, a new perspective on low-density lipoprotein cholesterol and/or non–high-density lipoprotein cholesterol treatment goals, and use of global risk assessment to guide primary prevention.5 These approaches are consistent with the existing and widely used paradigm of matching the intensity of preventive efforts with an individual’s absolute risk. Among the tools provided to support clinicians in implementing the new guidelines is a risk calculator to be used to determine 10-year risk for myocardial infarction and stroke among adults aged 40 to 79 years. It uses an updated equation developed from large, racially and geographically diverse community-based populations and includes race, gender, age, total cholesterol, high-density lipoprotein cholesterol, blood pressure, use of blood pressure medication, diabetes status, and smoking status. A downloadable spreadsheet enabling estimation of 10-year and lifetime risk for ASCVD and a Web-based calculator are available at http://my.americanheart.org/cvriskcalculator.6 If after quantitative risk assessment, a risk-based treatment decision is uncertain, additional risk measures that support revising risk assessment upward may be considered to inform treatment decision making: family history of premature cardiovascular disease (first degree male relative <55 years or female relative <65 years), high-sensitivity C-reactive protein (≥2 mg/L), coronary artery calcium score (≥300 Agatston units or ≥75th percentile for age, sex, and ethnicity), or ankle-brachial index (<0.9).4 The goal of this risk-based framework is to target treatment to those most likely to benefit without undue risk for harm, in the context of a risk discussion. A risk discussion could include the assessment of the individual’s risk for ASCVD and potential benefits, negative aspects, risks, and patient preferences regarding initiation of relevant preventive therapies. Guideline development is a dynamic process; as new evidence becomes available, guidelines will be revised and promulgated. Research in process and future research suggested by the Expert Panels is designed to address gaps in our existing evidence with the ultimate goal of promoting optimal cardiovascular health and quality of life for all individuals. To incorporate the clinical practice changes indicated in the 2013 evidence-based guidelines for cardiovascular prevention, we must become familiar with the new clinical recommendations and identify effective implementation strategies. It is likely that professional education materials, paper- and computer-based treatment algorithms, protocols, and other clinical tools, as well as patient-facing materials, will be revised to reflect new approaches for reducing cardiovascular risk. Cardiovascular nurses are well prepared and positioned to assume leadership roles in these processes." @default.
• W2022320883 created "2016-06-24" @default.
• W2022320883 creator A5017138956 @default.
• W2022320883 creator A5045684619 @default.
• W2022320883 creator A5051473305 @default.
• W2022320883 date "2014-03-01" @default.
• W2022320883 modified "2023-09-26" @default.
• W2022320883 title "New Cardiovascular Prevention Guidelines Offer a New Approach and Effective Strategies" @default.
• W2022320883 doi "https://doi.org/10.1097/jcn.0000000000000135" @default.
• W2022320883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24504020" @default.
• W2022320883 hasPublicationYear "2014" @default.
• W2022320883 type Work @default.
• W2022320883 sameAs 2022320883 @default.
• W2022320883 citedByCount "1" @default.
• W2022320883 countsByYear W20223208832014 @default.
• W2022320883 crossrefType "journal-article" @default.
• W2022320883 hasAuthorship W2022320883A5017138956 @default.
• W2022320883 hasAuthorship W2022320883A5045684619 @default.
• W2022320883 hasAuthorship W2022320883A5051473305 @default.
• W2022320883 hasBestOaLocation W20223208831 @default.
• W2022320883 hasConcept C12174686 @default.
• W2022320883 hasConcept C126322002 @default.
• W2022320883 hasConcept C127413603 @default.
• W2022320883 hasConcept C142724271 @default.
• W2022320883 hasConcept C168563851 @default.
• W2022320883 hasConcept C17744445 @default.
• W2022320883 hasConcept C177713679 @default.
• W2022320883 hasConcept C1862650 @default.
• W2022320883 hasConcept C199539241 @default.
• W2022320883 hasConcept C2779134260 @default.
• W2022320883 hasConcept C2779473830 @default.
• W2022320883 hasConcept C2780182762 @default.
• W2022320883 hasConcept C2780586474 @default.
• W2022320883 hasConcept C2780645631 @default.
• W2022320883 hasConcept C2909478654 @default.
• W2022320883 hasConcept C38652104 @default.
• W2022320883 hasConcept C41008148 @default.
• W2022320883 hasConcept C511355011 @default.
• W2022320883 hasConcept C512399662 @default.
• W2022320883 hasConcept C71924100 @default.
• W2022320883 hasConcept C78519656 @default.
• W2022320883 hasConceptScore W2022320883C12174686 @default.
• W2022320883 hasConceptScore W2022320883C126322002 @default.
• W2022320883 hasConceptScore W2022320883C127413603 @default.
• W2022320883 hasConceptScore W2022320883C142724271 @default.
• W2022320883 hasConceptScore W2022320883C168563851 @default.
• W2022320883 hasConceptScore W2022320883C17744445 @default.
• W2022320883 hasConceptScore W2022320883C177713679 @default.
• W2022320883 hasConceptScore W2022320883C1862650 @default.
• W2022320883 hasConceptScore W2022320883C199539241 @default.
• W2022320883 hasConceptScore W2022320883C2779134260 @default.
• W2022320883 hasConceptScore W2022320883C2779473830 @default.
• W2022320883 hasConceptScore W2022320883C2780182762 @default.
• W2022320883 hasConceptScore W2022320883C2780586474 @default.
• W2022320883 hasConceptScore W2022320883C2780645631 @default.
• W2022320883 hasConceptScore W2022320883C2909478654 @default.
• W2022320883 hasConceptScore W2022320883C38652104 @default.
• W2022320883 hasConceptScore W2022320883C41008148 @default.
• W2022320883 hasConceptScore W2022320883C511355011 @default.
• W2022320883 hasConceptScore W2022320883C512399662 @default.
• W2022320883 hasConceptScore W2022320883C71924100 @default.
• W2022320883 hasConceptScore W2022320883C78519656 @default.
• W2022320883 hasIssue "2" @default.
• W2022320883 hasLocation W20223208831 @default.
• W2022320883 hasLocation W20223208832 @default.
• W2022320883 hasOpenAccess W2022320883 @default.
• W2022320883 hasPrimaryLocation W20223208831 @default.
• W2022320883 hasRelatedWork W146067411 @default.
• W2022320883 hasRelatedWork W2090530110 @default.
• W2022320883 hasRelatedWork W2356089912 @default.
• W2022320883 hasRelatedWork W2461640252 @default.
• W2022320883 hasRelatedWork W3159250744 @default.
• W2022320883 hasRelatedWork W4200158653 @default.
• W2022320883 hasRelatedWork W4249487090 @default.
• W2022320883 hasRelatedWork W4256514411 @default.
• W2022320883 hasRelatedWork W4292236216 @default.
• W2022320883 hasRelatedWork W2083697902 @default.
• W2022320883 hasVolume "29" @default.
• W2022320883 isParatext "false" @default.
• W2022320883 isRetracted "false" @default.
• W2022320883 magId "2022320883" @default.
• W2022320883 workType "article" @default.